APOE Gene and rs332: Understanding Genetic Risk Factors
The APOE gene is a critical component in human health, responsible for producing a protein that transports cholesterol and fats throughout the body. Variations within this gene, including those related to the rs332 locus, are well-studied for their significant associations with late-onset Alzheimer's disease risk.
What each genotype means
APOE ε2/ε2 genotype
This genotype corresponds to the ε2/ε2 isoform of the apolipoprotein E protein. Research suggests this profile is often associated with a lower risk of late-onset Alzheimer's disease compared to the more common ε3/ε3 genotype. Please discuss any concerns regarding cardiovascular health or lipid profiles with your clinician, as this genotype can influence cholesterol metabolism.
This is the rarest of the common APOE genotypes, typically found in less than 1% of the general population.
APOE ε2/ε3 genotype
This genotype corresponds to the ε2/ε3 isoform of the apolipoprotein E protein. Studies indicate this profile is generally associated with a neutral or slightly protective effect regarding the risk of late-onset Alzheimer's disease. As with all APOE genotypes, it plays a role in lipid transport, so you should consult your healthcare provider regarding routine cardiovascular and cholesterol monitoring.
This genotype is relatively common, carried by approximately 10% to 15% of individuals in many populations.
APOE ε3/ε3 genotype
This genotype corresponds to the ε3/ε3 isoform, which is considered the most common or 'neutral' form of the apolipoprotein E protein. It serves as the baseline for assessing Alzheimer's disease risk in most clinical research. While it does not carry the elevated risk associated with the ε4 allele, maintaining a heart-healthy lifestyle remains important for overall well-being.
This is the most frequent APOE genotype, found in roughly 60% to 70% of the general population.
Understanding the APOE Gene
The APOE gene provides instructions for making a protein called apolipoprotein E. This protein combines with fats in the body to form lipoproteins, which are responsible for packaging cholesterol and other fats and carrying them through the bloodstream. In the brain, apolipoprotein E is the primary cholesterol carrier and plays a vital role in maintaining the health of neurons and supporting the repair of brain cells. Because cholesterol transport is essential for normal cellular function, the APOE gene is highly conserved and active in various tissues, particularly the liver and the brain. Disruptions in how this protein functions can impact lipid metabolism and have been linked to various neurological and cardiovascular conditions.
The Role of APOE Alleles
The APOE gene exists in three common forms, or alleles, known as ε2, ε3, and ε4. These alleles are defined by specific variations at two locations in the gene, often referred to as rs429358 and rs7412. The ε3 allele is the most common and is generally considered to have a neutral effect on health. In contrast, the ε4 allele is widely recognized in scientific literature as a significant genetic risk factor for late-onset Alzheimer's disease. Conversely, the ε2 allele is often studied for its potential protective effects. Because individuals inherit one copy of the gene from each parent, the combination of these alleles—such as 3/3, 3/4, or 4/4—determines an individual's specific APOE profile, which researchers use to study disease susceptibility.
Research and Evidence Strength
The association between the APOE ε4 allele and late-onset Alzheimer's disease is one of the most robust findings in human genetics. Large-scale studies and meta-analyses have consistently shown that individuals carrying one or two copies of the ε4 allele have an increased statistical likelihood of developing Alzheimer's disease compared to those with the ε3/ε3 genotype. Research indicates that the risk is dose-dependent, meaning that individuals with two copies of the ε4 allele generally face a higher risk and potentially an earlier age of onset than those with a single copy. While this evidence is strong, it is important to note that carrying the ε4 allele does not guarantee that an individual will develop the disease, nor does its absence guarantee protection.
Population Frequency and Diversity
The frequency of APOE alleles varies significantly across different ancestral populations. The ε4 allele, while common, is not distributed uniformly; its frequency typically ranges from 5% to 15% in many global populations, though it can be higher or lower depending on specific geographic and ethnic backgrounds. Understanding these frequency differences is a major focus of modern genomics, as it helps researchers account for population-specific health disparities. Because allele frequencies can shift based on local ancestry, scientists emphasize the importance of diverse study cohorts to ensure that genetic risk assessments are accurate and applicable across all groups of people.
Interpreting Genetic Information
Genetic information regarding APOE can be complex and is best interpreted in the context of a person's overall health, family history, and lifestyle factors. It is crucial to understand that genetic risk is not a medical diagnosis. Many people who carry the ε4 allele never develop Alzheimer's disease, and many who do not carry it still develop the condition. If you have questions about your genetic profile or concerns about cognitive health, it is essential to consult with a healthcare professional or a genetic counselor. They can provide personalized guidance, help you understand the limitations of genetic testing, and discuss appropriate health screenings or lifestyle modifications that may support long-term brain health.
How common is this variant?
The ε4 allele frequency varies by ancestry, typically ranging from 5% to 15% in many populations, with specific combinations like 4/4 occurring in approximately 2% to 5% of people.
Frequently asked questions
Does having the APOE ε4 allele mean I will get Alzheimer's?
No, having the APOE ε4 allele does not mean you will develop Alzheimer's disease. It is a risk factor, meaning it increases the statistical likelihood, but it is not a deterministic cause.
Can I change my APOE genotype?
No, your APOE genotype is inherited from your parents and remains the same throughout your life. You cannot change your genetic sequence.
Should I get tested for APOE?
Genetic testing for APOE is a personal decision that should be discussed with a doctor or genetic counselor. It is important to consider how you would use the information and whether it would be helpful for your health planning.
What is the difference between ε2, ε3, and ε4?
These are different versions of the APOE gene. The ε3 allele is the most common and neutral, ε2 is often considered protective, and ε4 is associated with an increased risk of Alzheimer's disease.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs332?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in APOE
Variant in the APOE/TOMM40 locus associated with late-onset Alzheimer's disease risk.
Downstream variant in the APOE region associated with lipid metabolism profiles and healthspan indicators.
Variant (c.497G>A, p.Arg166Gln) in the APOE gene known as Apolipoprotein E4 Christchurch, which has been shown in clinical case studies to confer resistance to familial Alzheimer's disease pathology.
Upstream regulatory variant influencing APOE transcription and plasma lipid modulation.
Defines the APOE ε2 allele, associated with lower LDL cholesterol and reduced risk of Alzheimer's disease.
Regulatory variant in the APOE promoter region modulating transcriptional activity and risk for late-onset neurodegeneration.